title: Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation.
authors.affiliation: Duke University Medical Center, Durham, NC 27710, USA. olsen001@mc.duke.edu
authors.forename: Elise A
authors.initials: EA
authors.lastname: Olsen
authors.forename: Maria K
authors.initials: MK
authors.lastname: Hordinsky
authors.forename: Vera H
authors.initials: VH
authors.lastname: Price
authors.forename: Janet L
authors.initials: JL
authors.lastname: Roberts
authors.forename: Jerry
authors.initials: J
authors.lastname: Shapiro
authors.forename: Doug
authors.initials: D
authors.lastname: Canfield
authors.forename: Madeleine
authors.initials: M
authors.lastname: Duvic
authors.forename: Lloyd E
authors.initials: LE
authors.lastname: King
authors.forename: Amy J
authors.initials: AJ
authors.lastname: McMichael
authors.forename: Valerie A
authors.initials: VA
authors.lastname: Randall
authors.forename: Maria L
authors.initials: ML
authors.lastname: Turner
authors.forename: Leonard
authors.initials: L
authors.lastname: Sperling
authors.forename: David A
authors.initials: DA
authors.lastname: Whiting
authors.forename: David
authors.initials: D
authors.lastname: Norris
mesh_terms: D000506:Alopecia Areata / Q000145:classification* / Q000473:pathology; D002986:Clinical Trials as Topic; D015897:Comorbidity; D023381:Endpoint Determination; D006801:Humans; D009262:Nails / Q000473:pathology; D012720:Severity of Illness Index